MTOR and breast carcinoma: An elevation in endocannabinoids receptor (CB1-R) expression following quercetin treatment has been noted in colon and breast cancer cell lines, which in turn inhibited survival signaling pathways such as PI3K/Akt/mTOR [128,129].